Christiana Bardon
Showing 1–2 of 2 transcripts.
- Milken Institute56 min
Asia's Next Frontier: Building Capabilities for Translational Research
Tanisha Carino, Christiana Bardon, Carl Firth, Annalisa Jenkins, Baiju Shah, Chris Bardone
Faster Cures and Milken Institute convene Asian policymakers and industry leaders to address the critical "Valley of Death" separating basic science from clinical cures across the region's rapidly expanding R&D landscape. The discussion highlights Singapore's strategic shift toward translational funding and data infrastructure, China's accelerated regulatory reforms, and the Harrington Project's hybrid model designed to bridge skill and capital gaps for high-burden diseases. While genomic initiatives and reimbursement changes promise to modernize access, the session concludes that overcoming cultural barriers in patient advocacy and workforce specialization remains essential for translating scientific knowledge into effective patient treatments.
- Milken Institute1h 2m
Paying for Cures
Colleen Rye, Christiana Bardon, Louis DeGennaro, Joe La Barge, Mark Trusheim, Cynthia Verst, Cindy Virst, Mark Trusseimer, Chris Barden, Joe Medina, Eric Schmidt, Lou, Louis Kombolaini, John McWhorter, Tanisha Carino, Martha Minowski
Discussions on the evolution of curative gene therapies analyze the projected surge of over 500 pipeline candidates and the necessary shift from chronic treatment models to one-time cures that disrupt traditional pricing structures. Industry experts highlight innovative financial mechanisms, including outcomes-based rebates and installment payments, designed to navigate complex regulatory hurdles like Medicaid best price rules and FASB accounting volatility while addressing manufacturing costs. Despite significant challenges in social equity and international reimbursement disparities, the consensus suggests that historical precedents and market-driven competition will ultimately sustain a system capable of integrating these high-cost, durable medical breakthroughs.